Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
SmartCella Holding AB logo — SmartCella is a global biopharma company with a vision to re...

SmartCella Holding AB

SmartCella is a global biopharma company with a vision to revolutionize targeted therapeutic delivery.

Founded 2014 Sweden Sweden 72 employees Total: $378.00M Biotechnology, Health Care +2

General Information

Company Name SmartCella Holding AB
Founded Year 2014
Location Sweden Sweden
Employees 72
Industries Biotechnology, Health Care, Health and Wellness +1
Business Model B2B, B2D
Revenue Model Licensing, Product Sales, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with SmartCella Holding AB. To contact SmartCella Holding AB, visit smartcella.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does SmartCella Holding AB compare?

A PDF of SmartCella Holding AB and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting SmartCella Holding AB soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About SmartCella Holding AB

SmartCella Holding AB is a biopharmaceutical company aiming to revolutionize targeted therapeutic delivery with cutting-edge solutions. Founded in 2014 and based in Sweden, the company is rooted in world-class science and research from Karolinska Institutet.

Operating in the Biotechnology and Health Care sectors, SmartCella focuses on two key areas: Targeted Delivery and Regenerative Medicines. Their flagship product, the Extroducer®, is a novel endovascular delivery device facilitating targeted therapeutic delivery to challenging areas like hard-to-reach organs and tumors. This innovation underscores their commitment to developing therapies for difficult-to-treat diseases.

Recently, SmartCella secured a significant €50.00M in a Private Equity Round on 08 July 2024, attracting prominent investors such as AP4, Swedish pension fund AMF, SEB, RoosGruppen, AstraZeneca, and Handelsbanken Fonder. This funding highlights substantial investor confidence in their potential to deliver life-changing treatments globally.

Business keywords: Biopharma, Targeted Therapeutic Delivery, Biotech Methods, Medical Science, Living Systems Therapies, Difficult-to-Treat Diseases, Delivery Solutions, Therapy Development, Karolinska Institutet, Novel Delivery Platforms, Endovascular Delivery Device, Cell Therapies Manufacturing, Targeted Delivery, Regenerative Medicines, Cardiac Disease Therapies

Services & Products

Device-based Delivery
Cell Therapies
Modified Cell Therapies

Target Customers

Patients in need of advanced therapies Healthcare Providers Medical Researchers Biotech Innovators

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Late VC €50.00M 5
AMF AP4
AMF, AP4 +3
01 Jul 2024
Early VC kr328.00M 8
Kennet Partners AMF AP4
Kennet Partners, AMF +6
01 Sep 2021

SmartCella Holding AB Alternatives & Competitors

View All Alternatives
SmartCella Holding AB vs
Alumis
Alumis United States

Transforming the lives of patients living with immune-mediated diseases using a precision approach.

Series C
249 employees
Biotechnology, Health Care
SmartCella Holding AB vs
Basilard BioTech, Inc.
Basilard BioTech, Inc. United States

Nanomechanical Gene Delivery to Transform the Engineering of Cell Based Therapies

Seed
5 employees
Biopharma, Biotechnology
SmartCella Holding AB vs
Poseida Therapeutics, Inc.
Poseida Therapeutics, Inc. United States

A Member of the Roche Group

Acquired
81 employees
Biopharma, Biotechnology
View all alternatives

FAQ About SmartCella Holding AB

SmartCella is a global biopharma company with a vision to revolutionize targeted therapeutic delivery.
SmartCella Holding AB was founded in 2014.
SmartCella Holding AB is headquartered in Sweden.
SmartCella Holding AB operates in Biotechnology, Health Care, Health and Wellness and Life Sciences. Its work centres on Biopharma, Targeted Therapeutic Delivery, Biotech Methods and Medical Science. Its customers include Patients in need of advanced therapies, Healthcare Providers and Medical Researchers.
SmartCella Holding AB has a B2B and B2D business model. Its revenue comes from Licensing, Product Sales and Service Fee.
SmartCella Holding AB has approximately 72 employees.
SmartCella Holding AB has completed 2 funding rounds, raising a total of $378.00M.
SmartCella Holding AB offers: Device-based Delivery, Cell Therapies, Modified Cell Therapies.
Top alternatives and competitors to SmartCella Holding AB include Alumis, Basilard BioTech, Inc., Poseida Therapeutics, Inc., Rampart Bioscience, VectivBio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SmartCella Holding AB and Alumis are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for SmartCella Holding AB, https://bouncewatch.com/company/smartcella, updated 5 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes